Onconetix, Inc. Operating Lease, Lease Income, Lease Payments
Onconetix, Inc. (ONCO) reported Operating Lease, Lease Income, Lease Payments of $4.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2025-06-02
- Onconetix, Inc. operating lease, lease income, lease payments for the quarter ending 2024-09-30 was $0.00.
- Onconetix, Inc. operating lease, lease income, lease payments for the quarter ending 2023-03-31 was $4.00K.
- Onconetix, Inc. operating lease, lease income, lease payments for fiscal 2023 was $4.00K, a 66.67% decline from fiscal 2022.
- Onconetix, Inc. operating lease, lease income, lease payments for fiscal 2022 was $12.00K.
| Period end | Operating Lease, Lease Income, Lease Payments 3 month | Operating Lease, Lease Income, Lease Payments 6 month | Operating Lease, Lease Income, Lease Payments 9 month | Operating Lease, Lease Income, Lease Payments 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $4.00K 10-Q · filed 2024-12-10 | ||
| 2024-06-30 | $4.00K 10-Q · filed 2024-08-29 | |||
| 2023-12-31 | $4.00K 10-K · filed 2025-06-02 | |||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-20 | |||
| 2022-12-31 | $12.00K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |